Skip to main content

Table 1 Body, liver, relative liver weights, and length of colon.

From: Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands

Group no. Treatment No. of mice Body weight (g) Liver weight (g) Relative liver weight (g/100 g body weight) Length of colon (cm)
1 AOM/DSS 10 36.6 ± 5.6 a 2.0 ± 0.5 5.5 ± 0.7 11.5 ± 2.1
2 AOM/DSS/0.04% Nimesulide 10 44.8 ± 5.6 b 2.3 ± 0.3 5.3 ± 0.7 12.1 ± 1.3
3 AOM/DSS/0.05% Troglitazone 10 43.6 ± 6.3 c 2.5 ± 0.5 d 5.7 ± 1.0 11.4 ± 1.1
4 AOM/DSS/0.05% Bezafibrate 10 42.4 ± 6.4 d 2.8 ± 0.7e 6.6 ± 1.5 12.1 ± 1.4
5 0. 04% Nimesulide 5 39.9 ± 7.3 2.0 ± 0.3 5.0 ± 0.9 12.5 ± 0.7
6 0. 05% Troglitazone 5 39.8 ± 4.0 2.1 ± 0.3 5.2 ± 0.7 11.9 ± 0.9
7 0. 05% Bezafibrate 5 46.8 ± 9.6 2.7 ± 0.5 5.8 ± 0.9 12.6 ± 1.4
8 AOM 5 42.8 ± 2.6 1.9 ± 0.1 4.5 ± 0.4 12.3 ± 1.2
9 DSS 6 34.4 ± 2.8f 1.8 ± 0.2 5.2 ± 0.7 12.3 ± 0.6
10 None 5 43.2 ± 6.5 2.0 ± 0.2 4.8 ± 0.8 12.0 ± 0.6
  1. a Mean ± SD.
  2. b-e Significantly different from group 1 by Student's t-test (b P < 0.005, c P < 0.02, d P < 0.05, and e P < 0.01).
  3. f Significantly different from group 1 by Welch's t-test (f P < 0.05).
\